logo
Wacker Biotech B.V.
Chemicals
Paasheuvelweg 30
1105 BJ
https://www.wacker.com/cms/en-de/about-wacker/wacker-at-a-glance/production-sites/amsterdam.html
With the takeover of SynCo Bio Partners B.V. in Amsterdam, the Netherlands, in 2018 Wacker Chemie AG strengthened its pharmaceutical protein business and expanded its portfolio – an important step to keep pace with the rapidly growing biologics market. Following the acquisition in April last year, the new name Wacker Biotech B.V. came into effect in November. Just like Wacker Biotech GmbH, Wacker Biotech B.V. is a full-service contract manufacturer of biopharmaceutical proteins based on microbial systems. The new Amsterdam site joins Jena and Halle as Wacker Biotech’s third state-of-the-art production site that guarantees top quality standards in accordance with GMP (good manufacturing practice).
Entity Settings

Category
Main Holding Company or Operations
Status
A
V
P
Sh
System Info

Modified by
UserPic  Braun, Uwe
Modified
11/1/2022 2:03 PM
Added by
UserPic  Braun, Uwe
Added
11/1/2022 1:10 PM
Solutions
Solutions

Solution-Reference:

#E818

No Services yet available.
Enquire in Solutions how we can help you.

  Entity Communicator  (including Site Messages)
Site Title Date
  Sites Quick Access
Site Location Country
Wacker Amsterdam Amsterdam

Featured Function

Interests Map View the Operations, Shareholding, and Subsidiaries of this Entity